Boyd Peter E.
SEC CIK 1739816 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | See Remarks | 284.0K | $6,251 | $336.8K | 15 | 2022-06-08 | 2026-09-09 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-10 09:21 | 2026-09-09 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | CHRO | X - OptEx | $0.96 | +2,293 | 284.0K | +0.8% | +$2,201 |
| 2026-05-07 17:34 | 2026-05-05 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | CHRO | F - Tax | $4.18 | -56.8K | 281.7K | -17% | -$237.3K | |
| D | 2026-03-11 | 2026-03-09 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | CHRO | A - Grant | $0.00 | +80.0K | 368.3K | +28% | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | CHRO | S - Sale | $4.17 | -29.8K | 338.5K | -8% | -$124.3K |
| 2025-12-05 | 2025-12-04 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | CHRO | A - Grant | $0.00 | +20.0K | 288.3K | +7% | $0 | |
| 2025-10-17 | 2025-10-15 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remarks | S - Sale | $7.00 | -10.0K | 268.3K | -4% | -$70.0K | |
| 2025-09-29 | 2025-09-26 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remarks | S - Sale | $6.30 | -10.0K | 278.3K | -3% | -$63.0K | |
| 2025-09-08 | 2025-09-05 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remarks | S - Sale | $5.30 | -15.0K | 288.3K | -5% | -$79.5K | |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remark | F - Tax | $2.65 | -14.3K | 303.3K | -5% | -$37.9K |
| D | 2025-03-11 | 2025-03-07 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remark | A - Grant | $0.00 | +80.0K | 317.6K | +34% | $0 |
| 2024-03-12 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remark | F - Tax | $4.88 | -8,370 | 237.6K | -3% | -$40.8K | |
| D | 2024-03-11 | 2024-03-07 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remark | A - Grant | $0.00 | +86.2K | 246.0K | +54% | $0 |
| 2023-03-09 | 2023-03-09 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remark | A - Grant | $0.00 | +100.0K | 159.5K | +168% | $0 | |
| 2022-06-15 | 2022-06-14 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | SVP-Bus. Process, Info. Tech | P - Purchase | $0.81 | +5,000 | 59.5K | +9% | +$4,050 | |
| D | 2022-06-10 | 2022-06-08 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | SVP-Bus. Process, Info. Tech | P - Purchase | $0.96 | +2,293 | 54.5K | +4% | +$2,201 |
Purchase Sale Sale after option exercise All abbreviations